NCI
Get informed when a big investor buys or sells
+ FollowOvervalued by 179.3% based on the discounted cash flow analysis.
| Market cap | $5.59 Million |
|---|---|
| Enterprise Value | $53.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | -2.88 |
| Outstanding Shares | 508,000 |
| P/E Ratio | 125.19 |
|---|---|
| PEG | -41.85 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.1 |
| Enterprise Value to Revenue | 0.47 |
| Enterprise Value to EBIT | 32.3 |
| Enterprise Value to Net Income | -133 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | 0.89 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data